1. Home
  2. SAGE vs MYE Comparison

SAGE vs MYE Comparison

Compare SAGE & MYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • MYE
  • Stock Information
  • Founded
  • SAGE 2010
  • MYE 1933
  • Country
  • SAGE United States
  • MYE United States
  • Employees
  • SAGE N/A
  • MYE N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • MYE Auto Parts:O.E.M.
  • Sector
  • SAGE Health Care
  • MYE Consumer Discretionary
  • Exchange
  • SAGE Nasdaq
  • MYE Nasdaq
  • Market Cap
  • SAGE 415.0M
  • MYE 339.4M
  • IPO Year
  • SAGE 2014
  • MYE N/A
  • Fundamental
  • Price
  • SAGE $7.79
  • MYE $10.29
  • Analyst Decision
  • SAGE Hold
  • MYE Hold
  • Analyst Count
  • SAGE 19
  • MYE 1
  • Target Price
  • SAGE $9.88
  • MYE N/A
  • AVG Volume (30 Days)
  • SAGE 1.2M
  • MYE 311.3K
  • Earning Date
  • SAGE 04-29-2025
  • MYE 05-01-2025
  • Dividend Yield
  • SAGE N/A
  • MYE 5.32%
  • EPS Growth
  • SAGE N/A
  • MYE N/A
  • EPS
  • SAGE N/A
  • MYE 0.19
  • Revenue
  • SAGE $41,243,000.00
  • MYE $836,281,000.00
  • Revenue This Year
  • SAGE $100.64
  • MYE $2.46
  • Revenue Next Year
  • SAGE $70.19
  • MYE $2.72
  • P/E Ratio
  • SAGE N/A
  • MYE $53.42
  • Revenue Growth
  • SAGE N/A
  • MYE 2.85
  • 52 Week Low
  • SAGE $4.62
  • MYE $9.06
  • 52 Week High
  • SAGE $14.97
  • MYE $23.05
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 56.30
  • MYE 47.36
  • Support Level
  • SAGE $7.56
  • MYE $9.07
  • Resistance Level
  • SAGE $7.89
  • MYE $10.40
  • Average True Range (ATR)
  • SAGE 0.36
  • MYE 0.59
  • MACD
  • SAGE 0.06
  • MYE 0.08
  • Stochastic Oscillator
  • SAGE 88.03
  • MYE 73.35

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About MYE Myers Industries Inc.

Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.

Share on Social Networks: